Close
ACHEMA MIDDLE EAST 2026

Tag: America

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

Roche’s Genentech Launches New Manufacturing Facility in USA

Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement under which AbbVie will...

Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal

Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...

The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral vector-based immunotherapy for adult...

Popular